7.10
Precedente Chiudi:
$7.14
Aprire:
$7.12
Volume 24 ore:
2.19M
Relative Volume:
0.41
Capitalizzazione di mercato:
$2.54B
Reddito:
$9.68M
Utile/perdita netta:
$-250.64M
Rapporto P/E:
-5.0722
EPS:
-1.3998
Flusso di cassa netto:
$-89.83M
1 W Prestazione:
+2.16%
1M Prestazione:
+8.73%
6M Prestazione:
+100.00%
1 anno Prestazione:
+55.70%
Precigen Inc Stock (PGEN) Company Profile
Nome
Precigen Inc
Settore
Industria
Telefono
301-556-9900
Indirizzo
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PGEN
Precigen Inc
|
7.10 | 2.66B | 9.68M | -250.64M | -89.83M | -1.3998 |
|
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Iniziato | JP Morgan | Neutral |
| 2022-11-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Iniziato | Stifel | Buy |
| 2021-02-22 | Iniziato | Wells Fargo | Overweight |
| 2021-02-18 | Iniziato | B. Riley Securities | Buy |
| 2020-05-08 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Precigen Inc Borsa (PGEN) Ultime notizie
Precigen (PGEN) officer targets $259,935 insider stock sale - Stock Titan
Precigen (NASDAQ:PGEN) Trading Down 3.6%Here's Why - MarketBeat
3 Growth Companies With High Insider Ownership And 55% Earnings Growth - simplywall.st
$Precigen (PGEN.US)$ keep it up! - Moomoo
Precigen (NASDAQ:PGEN) Hits New 12-Month HighTime to Buy? - MarketBeat
Precigen stock hits 52-week high at 7.33 USD By Investing.com - Investing.com Australia
Reasons Why Investors Should Consider Betting on PGEN Stock - TradingView
Precigen (PGEN) Stock: Ends Up by 6.30% at $7.17 in the Latest Session; Key Range: Support at $6.81 and Resistance at $7.53 Frame the Range under the Current SnapshotPut Spread Alert - vinanet.vn
Stock Traders Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Alpine Woods Capital Investors LLC Takes $1.31 Million Position in Precigen, Inc. $PGEN - MarketBeat
$Precigen (PGEN.US)$ DCA'd Up. Ready for the next leg higher - Moomoo
Precigen (PGEN) Price and Levels: Finishes 3.05% Higher at $6.75 in the Latest Session; $6.41 and $7.09 Define the Nearby Reference Levels at the CloseCounter Trend Trade - vinanet.vn
Precigen Inc. (PGEN) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Precigen (NASDAQ:PGEN) Stock Price Up 5.5%Time to Buy? - MarketBeat
Precigen Inc (PGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precigen (NASDAQ:PGEN) Trading Down 5.5%What's Next? - MarketBeat
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice - Yahoo Finance
Precigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? - Yahoo Finance
US High Growth Tech Stocks To Watch: 3 Top Picks - simplywall.st
Precigen (PGEN) Q2 2026 Earnings Call Transcript - AOL.com
Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage - webull.com
Precigen (PGEN) Insider Rutul Shah Sells 32,739 Shares - GuruFocus
Precigen jumps 266% on FDA approval but faces h... - Pluang
Wall Street Zen Upgrades Precigen (NASDAQ:PGEN) to "Strong-Buy" - MarketBeat
Precigen: Has To Grow Into Its Valuation - Seeking Alpha
Precigen (NASDAQ:PGEN) COO Sells $224,589.54 in Stock - MarketBeat
COO sale: Precigen (PGEN) insider trades 32,739 shares via plan - Stock Titan
Merck affiliates disclose 4.9% Precigen (NASDAQ: PGEN) ownership - Stock Titan
HC Wainwright Has Positive Outlook for Precigen Q3 Earnings - MarketBeat
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Zacks Research - MarketBeat
Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential With An 80% Upside - DirectorsTalk Interviews
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement (PGEN) - Seeking Alpha
PRECIGEN, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $18 FROM $14 - webull.com
Precigen (NASDAQ: PGEN) Form 144 covers 32,739 common shares for sale - Stock Titan
HC Wainwright Predicts Precigen's Q4 Earnings (NASDAQ:PGEN) - MarketBeat
Results: Precigen, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - 富途牛牛
Precigen (NASDAQ:PGEN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Arrowstreet Capital Limited Partnership Acquires Shares of 395,695 Precigen, Inc. $PGEN - MarketBeat
Precigen, Inc. (PGEN) Interactive Stock Chart - Yahoo! Finance Canada
Germantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval - The Business Journals
Precigen (NASDAQ:PGEN) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Precigen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Precigen Inc (PGEN) (Q2 2026) Earnings Call Highlights: Revenue Surges 145% and Net Profit Achieved - GuruFocus
Is Precigen Inc (PGEN) Overvalued After Q2 Earnings Beat? GF Sco - GuruFocus
Earnings call transcript: Precigen tops Q2 2026 forecasts as PAPZIMEOS sales surge - Investing.com
Precigen (NASDAQ:PGEN) Announces Earnings Results - MarketBeat
Precigen, Inc. (PGEN) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Precigen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Precigen (PGEN) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Precigen Inc Earnings Call Transcript - GuruFocus
Precigen Inc Azioni (PGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):